The manufacturer of Tylenol, the best-selling form of acetaminophen, said Monday that it “strongly disagrees” with President Donald Trump’s suggestion that its ...
Sara Moniuszko is a health and lifestyle reporter at CBSNews.com. Previously, she wrote for USA Today, where she was selected to help launch the newspaper's wellness vertical. She now covers breaking ...
Ritwik is a passionate gamer who has a soft spot for JRPGs. He's been writing about all things gaming for six years and counting. Skyrim stays relevant in 2025 thanks to re-releases and thriving mod ...
Shares of Tylenol-maker Kenvue jumped more than 6% as trading opened Tuesday, a day after President Donald Trump linked the use of the drug’s active ingredient during pregnancy to increased risk for ...
Vanessa is a lead writer at CNET, reviewing and writing about the latest smartwatches and fitness trackers. She joined the brand first as an on-camera reporter for CNET's Spanish-language site, then ...
Jennie Richardson is a TV Features and Lists Writer for Collider, and a graduate student pursuing an MFA in Fiction Writing. In other words, she really loves stories. The first half of High ...
A pending announcement from the Trump administration linking pain relief drug acetaminophen with autism has stirred investor anxiety in the drug’s primary producer. The share price of Kenvue, the ...
Troubled auto part supplier First Brands Group is preparing to file for bankruptcy as soon as next week and is looking to secure a loan of at least $1 billion to keep the business running while it ...
TROY, Mich (WXYZ) — The family of Thomas Cooper has filed a $100 million civil lawsuit against The Oxford Center, its employees and a hyperbaric chamber ...
Electronic Arts, maker of video games like “Madden NFL,” “Battlefield,” and “The Sims,” is being acquired for $55 billion, the biggest leveraged buyout attempt in history. Under the terms of the deal ...
(Reuters) -Kenvue's shares climbed 6% on Tuesday, rebounding from a record low hit in the previous session, as analysts pointed to the lack of new scientific evidence from the White House to support ...
Sept 23 (Reuters) - Kenvue's (KVUE.N), opens new tab shares climbed 6% on Tuesday, rebounding from a record low hit in the previous session, as analysts pointed to the lack of new scientific evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback